Novartis takes aim at Roche's star MS drug

Swiss drugmaker Novartis on Friday stepped up its challenge to Roche's multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its cross-town rival's drug Ocrevus.


from Reuters: Health News https://ift.tt/2ML3o2v

Comentarii

Trimiteți un comentariu

Postări populare de pe acest blog

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

MinnPost provides updates on coronavirus in Minnesota Sunday through Friday. The information is published following a press phone call with members of the Walz administration or after the release of daily COVID-19 figures by the Minnesota Department of Health. Here are the latest updates from September 11, 2020: 82,716 confirmed cases; 1,897 deaths Thirteen more Minnesotans have died of COVID-19, the Minnesota Department of Health said Friday, for a total of 1,897. It was the second day in a row with more than 10 reported deaths — something that’s only happened one other time since June 19 and 20. Of the people whose deaths were announced Friday, three were in their 90s, six were in their 80s, three were in their 70s and one was in their 60s. Seven of the 13 deaths announced Friday were among residents of long-term care facilities. Of the 1,897 COVID-19 deaths reported in Minnesota, 1,382 have been among residents of long-term care. The current death toll only includes Minnesota...
Citiți mai multe